Lymphedema News and Research

RSS
Lymphedema is a condition that can cause significant swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for draining excess fluid from the body and is a key component of the immune system, is damaged or altered. In breast cancer patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that six percent to 40 percent of patients with breast cancer develop lymphedema, and that it often occurs within the first two years after surgery. For some cancer survivors and others at risk, a low level lymphedema can occur 10 years to 15 years following the initial primary treatment and develop into a condition that has a serious impact on overall health and quality of life.
UCSF study evaluates genetic predictors of lymphedema in women

UCSF study evaluates genetic predictors of lymphedema in women

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

Trends in patient worry and risk-reducing behaviors in women undergoing breast cancer treatment

African American women less likely to receive axillary SLN biopsy for breast cancer

African American women less likely to receive axillary SLN biopsy for breast cancer

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Exercise at home may relieve lymphedema in breast cancer

Exercise at home may relieve lymphedema in breast cancer

Full-body exercise and CDT best ways to minimize lymphedema

Full-body exercise and CDT best ways to minimize lymphedema

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

Premier, ArjoHuntleigh announce three-year contract for vascular compression therapy systems

Devon Medical Products receives PDAC approval for extriCARE 2400 system

Devon Medical Products receives PDAC approval for extriCARE 2400 system

Four new studies on the treatment of early breast cancer

Four new studies on the treatment of early breast cancer

Study to investigate how breast cancer patients might benefit from exercise

Study to investigate how breast cancer patients might benefit from exercise

Liposuction effective in treating submental lymphedema in patients with head and neck cancer

Liposuction effective in treating submental lymphedema in patients with head and neck cancer

Preoperative breast cancer pain involves an inflammatory process

Preoperative breast cancer pain involves an inflammatory process

Innovative model of breast cancer rehabilitation

Innovative model of breast cancer rehabilitation

New supplement outlines prospective surveillance model for breast cancer

New supplement outlines prospective surveillance model for breast cancer

More than 60% of breast cancer survivors report post-treatment complications

More than 60% of breast cancer survivors report post-treatment complications

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

Transgenic mice to visualize metastasis and inflammation

Transgenic mice to visualize metastasis and inflammation

New imaging probes can non-invasively detect breast cancer lymph node metastasis

New imaging probes can non-invasively detect breast cancer lymph node metastasis

Prospective surveillance model can reduce treatment costs for breast cancer-related lymphedema

Prospective surveillance model can reduce treatment costs for breast cancer-related lymphedema